Risk factors in the origin of congenital left-ventricular outflow-tract obstruction defects of the heart: A population-based case-control study

Pediatric Cardiology

Volumn 35, Issue 1, 2014, Pages 108-120

  Csáky Szunyogh, Melinda ^a   Vereczkey, Attila ^b   Kósa, Zsolt ^b   Gerencsér, Balázs ^c   Czeizel, Andrew E ^d  

^a Hungarian Congenital Abnormalities Registry   (Hungary)

^b Versys Clinics   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^d FOUNDATION FOR THE COMMUNITY CONTROL OF HEREDITARY DISEASES   (Hungary)

Author keywords

Coarctation of the aorta; Hypoplastic left heart syndrome; Left ventricular outflow tract obstructive defects of the heart; Maternal diabetes; Panic disorder; Valvular aortic stenosis

Indexed keywords

AMPICILLIN; COTRIMOXAZOLE; ETACRYNIC ACID; FOLIC ACID; INSULIN; MAGNESIUM CITRATE; METHYLDOPA; PARACETAMOL; RITODRINE;

ACUTE DISEASE; ANEMIA; AORTA COARCTATION; AORTA STENOSIS; AORTA SUBVALVULAR STENOSIS; AORTA VALVE STENOSIS; ARTICLE; BICUSPID AORTIC VALVE; CARDIOVASCULAR RISK; CHILD DEATH; CHROMOSOME ABERRATION; CHRONIC DISEASE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; ECLAMPSIA; EDEMA; ENVIRONMENTAL EXPOSURE; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYDRAMNIOS; HYPERTROPHIC CARDIOMYOPATHY; HYPOPLASTIC LEFT HEART SYNDROME; IMMINENT ABORTION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL DIABETES MELLITUS; MATERNAL DISEASE; MATERNAL HYPERTENSION; NAUSEA AND VOMITING; NEWBORN; PANIC; PLACENTA DISORDER; POPULATION BASED CASE CONTROL STUDY; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURE LABOR; TERATOGENESIS; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VITAMIN SUPPLEMENTATION;

CASE-CONTROL STUDIES; DIABETES MELLITUS; FEMALE; FOLIC ACID; HEART DEFECTS, CONGENITAL; HUMANS; HUNGARY; MALE; MATERNAL WELFARE; PANIC DISORDER; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL CARE; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; ULTRASONOGRAPHY, PRENATAL; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 84893701427     PISSN: 01720643     EISSN: 14321971     Source Type: Journal    
DOI: 10.1007/s00246-013-0749-6     Document Type: Article

References (53)

1. Ács N, Bánhidy F, Puho E, Czeizel AE (2005) Maternal influenza during pregnancy and risk of congenital abnormalities in offspring. Birth Defects Res A Clin Mol Teratol 73:989-995
2. Ács N, Bánhidy F, Puho HE, Czeizel AE (2006) Maternal panic disorders and congenital abnormalities: a population-based case-control study. Birth Defects Res A Clin Mol Teratol 76:253-261
3. Bánhidy F, Dakhlaoui A, Puho HE, Czeizel AE (2011) Is there a reduction of congenital abnormalities in the offspring of diabetic pregnant women after folic acid supplementation? Congenit Anom 51:80-86
4. Beckman RH (1995) Coarctation of the aorta. In: Emmanouilides GC, Riemenschneider TA, Allen HD, Gutgesell HP (eds) Moss and Adam heart disease in infants, children, and adolescents, 5th edn. Williams and Wikins, Baltimore, MD, pp 1111-1128
5. Botto LD, Olney RS, Erickson JD (2004) Vitamin supplements and the risk for congenital anomalies other than neural-tube defects. Am J Med Genet 125:12-21
6. Botto LD, Lin AE, Riekle-Colarusso T, Malik S, Correa A (2007) Seeking causes: classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol 79:714-727
7. Calzolary E, Garani G, Cocchi G, Magnani C, Rivieri F, Neville A (2003) Congenital heart defects: 15 years of experience of the Emilia-Romagna Registry (Italy). Eur J Epidemiol 18:773-780
8. Carmichael SL, Shaw GM, Yang W, Abrams B, Edward J (2002) Maternal life event stress and congenital anomalies. Epidemiology 11:30-35
9. Clark EB (1996) Pathogenetic mechanisms of congenital cardiovascular malformations revisited. Semin Perinatol 20:465-472
10. Czeizel AE (1990) A case-control analysis of the teratogenic effects of co-trimoxazole. Reprod Toxicol 4:305-313
11. Czeizel AE (1996) Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet 62:179-183
12. Czeizel AE (1997) The first 25 years of the Hungarian Congenital Abnormality Registry. Teratology 55:299-305
13. Czeizel AE (2009) The estimation of human teratogenic/fetotoxic risk of exposures to drugs on the basis of Hungarian experiences: a critical evaluation of clinical and epidemiological models of human teratology. Expert Opin Drug Safe 8:283-303
14. Czeizel AE (2011) Periconceptional folic acid-containing multivitamin supplementation for prevention of neural-tube defects and cardiovascular malformations. Ann Nutr Metab 59:38-40
15. Czeizel AE, Dudás I (1992) Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Eng J Med 327:1832-1835
16. Czeizel AE, Sankaranarayanan K (1984) The load of genetic and partially genetic disorders in man. Congenital anomalies: estimates of detriment in terms of years of life lost and years of impaired life. Mutat Res 128:73-103
17. Czeizel AE, Vargha P (2004) Periconceptional folic acid/multivitamin supplementation and twin pregnancy. Am J Obstet Gynecol 191:790-794
18. Czeizel AE, Kamarás J, Balogh Ö, Szentpéteri J (1972) Incidence of congenital heart defects in Budapest. Acta Paediat Acad Sci Hung 13:191-202
19. Czeizel AE, Intody ZS, Modell B (1993) What proportion of congenital abnormalities can be prevented? Br Med J 306:499-503
20. Czeizel AE, Tóth M, Rockenbaer M (1996) Population-based case control study of folic acid supplementation during pregnancy. Teratology 53:345-351
21. Czeizel AE, Rockenbauer M, Siffel CS, Varga E (2001) Description and mission evaluation of the Hungarian case-control surveillance of congenital abnormalities, 1980-1996. Teratology 63:176-185
22. Czeizel AE, Rockenbauer M, Sorensen T, Olsen J (2001) A population-based case-control teratologic study of ampicillin treatment during pregnancy. Am J Obstet Gynecol 185:140-147
23. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J (2001) The teratogenic risk of trimethoprim-sulfonamides: a population-based case-control study. Reprod Toxicicol 15:637-646
24. Czeizel AE, Petik D, Vargha P (2003) Validation studies of drug exposures in pregnant women. Pharmacoepidemiol Drug Safe 12:409-416
25. Czeizel AE, Dobó M, Vargha P (2004) Hungarian cohort-controlled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities. Birth Defects Res A Clin Mol Teratol 70:853-861
26. Czeizel AE, Puho E, Ács N, Bánhidy F (2006) Inverse association between severe nausea and vomiting in pregnancy and some congenital abnormalities. Am J Med Genet 140A:453-462
27. Dolk H, Loane M, Garne R, European Surveillance of Congenital Anomalies (EUROCAT) Working Group (2011) Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005. Circulation 123:841-849
28. Ferencz C, Rubin JD, NcCarter RJ, Clark EB (1990) Maternal diabetes and cardiovascular malformations: predominance of double outlet right ventricle and truncus arteriosus. Teratology 41:319-326
29. Ferencz C, Loffredo CA, Rubin JD, Magee CA (1993) Epidemiology of congenital heart diseases. The Baltimore-Washington infant study: 1981-1989. Future Publication Co, Mount Kisco, NY
30. Ferencz C, Loffredo CA, Correa-Villasenor A, Wilson PD (1997) Genetic and environmental risk factors of major cardiovascular malformations: the Baltimore-Washington infant study: 1981-1989. Futura Publication Co, Armonk, NY
31. Fulton DR (2008) Congenital heart diseases in children and adolescent. In: Fuster V, Wals A, O'Rourke RA, Poole-Wilson P (eds) Hurst's the heart, 12th edn. McGraw Hill Medical, New York, NY, pp 1855-1921
32. Gelb BD (2004) Genetic basis of congenital heart disease. Curr Opin Cardiol 19:110-115
33. Goh YI, Bollano E, Einarson TR, Koren G (2006) Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis. J Obstet Gynaecol Can 28:686-690
34. Heinonen OP, Slone D, Shapiro A (1977) Birth defects and drugs in pregnancy. PSG Publishing, Littleton, MA
35. Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA (2000) Folic acid antagonists during pregnancy and risk of birth defects. N Engl J Med 343:1608-1614
36. Hoffman JIE, Kaplan S, Liberthson RR (2004) Prevalence of congenital heart disease. Am Heart J 147:425-439
37. Ionescu-Ittu R, Marelli AJ, Mackie AS, Pilote L (2009) Prevalence of severe congenital heart disease after folic acid fortification of grain products. Time trend analysis in Quebec, Canada. Brit Med J 338:b1673
38. Jenkins KJ, Correa A, Feinstein JA, Feinstein JA, Botto L, Britt AE et al (2007) Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on cardiovascular disease in the young. Endorsed by the American Academy of Pediatrics. Circulation 115:2995-3014
39. Lammer EJ (2007) Maternal stressful life events and risk of birth defects. Epidemiology 18:356-361
40. Loffredo CA, Wilson PD, Ferencz C (2001) Maternal diabetes: an independent risk factor for major cardiovascular malformations with increased mortality of affected infants. Teratology 64:98-101
41. McBride KL, Marengo L, Canfield M, Langlois P, Fixler D, Belmont JW (2005) Epidemiology of non-complex left ventricular outflow tract obstruction malformation (aortic valve stenosis, coarctation of the aorta, hypoplastic left heart syndrome) in Texas, 1999-2001. Birth Defects Res A Clin Mol Teratol 73:555-561
42. Mészáros M, Nagy A, Czeizel AE (1975) Incidence of congenital heart disease in Hungary. Hum Hered 25:513-519
43. Molsted-Pederson L, Tygstrup I, Pederson J (1964) Congenital malformations in newborn infants of diabetic women. Lancet 1:1124-1126
44. Pierpont ME, Basson CT, Benson DW, Gelb BD Jr, Giglia TM, Goldmuntz E et al (2007) Genetic basis for congenital heart defects: current knowledge. Circulation 115:3015-3038
45. Pradat O, Francannet C, Harris JA, Robert E (2003) The epidemiology of cardiovascular defects. Part I. A study based on data from three large registries of congenital malformations. Pediatr Cardiol 24:195-221
46. Puho E, Métneki J, Czeizel AE (2005) Maternal employment status and isolated orofacial clefts in Hungary. Centr Eur J Publ Health 13:144-148
47. Reller MD, Strickland MJ, Riehle-Colarusso F, Mahle WT, Correa A (2008) Prevalence of congenital heart defects in Metropolitan Atlanta, 1998-2005. J Pediatr 153:807-813
48. Rockenbauer M, Olsen J, Czeizel AE, Pedersen L, Sorensen HT, The EuroMAP Group (2001) Recall bias in a case-control study on the use of medicine during pregnancy. Epidemiology 12:401-466
49. Shepard TH, Lemire RJ (2004) Catalog of teratogenic agents, 11th edn. Johns Hopkins University Press, Baltimore, MD
50. Siu SC, Silversides CK (2010) Bicuspid aortic valve. J Am Coll Cardiol 55:2789-2800
51. Torfs CT, Curry CJ, Harris JA (1991) The descriptive epidemiology of hypoplastic left heart, coarctation of the aorta, and aortic stenosis. Teratology 43:448-449
52. van Beynum IM, Kapusta L, Bakker MK, den Heijer M, Blom HJ, de Walle HE (2010) Protective effect of periconceptional folic acid supplements on the risk of congenital heart defects: a registry-based case-control study in the northern Netherlands. Eur Heart J 31:464-471
53. Vereczkey A, Kósa Z, Csáky-Szunyogh M, Urbán R, Czeizel AE (2012) Birth outcomes of cases with left-sided obstructive defects of the heart in the function of maternal socio-demographic factors - A population-based case-control study. J Matern Fetal Neonatal Med 25:2536-2541